Pharma Journalist - Page 831 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Ionis Licenses Novel Antisense Drug for the Treatment of CNM to Dynacure

Innovus Pharma Announces Agreement with ACON Laboratories

Alcami Announces Manufacturing Agreement for Solasia’s API Darinaparsin

BioMatrix Family Of Companies expands with acquisition of Elwyn Pharmacy Group

Spark Therapeutics and Pfizer amend License Agreement for SPK-9001

Cambrex invests in new small scale capacity at its Charles City, Iowa facility

UK Drug Developer RxCelerate Opens First US Base in Boston

Boehringer and MiNA to Develop Novel Treatment approaches for Fibrotic Liver Diseases

Neurimmune collaborates with Ono Pharma in Neurodegenerative Diseases Field

Valeant Agrees to Sell Sprout to former shareholders of Sprout Pharmaceuticals